Major Shareholder Makes a Big Move with Bio Green Med Solution Stock!

New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on October 16, 2025.

Significant shareholder Yee Lung Ong has recently sold 135,793 shares of Bio Green Med Solution stock, amounting to a total sale value of $814,758.

Recent Updates on BGMS stock

In recent developments for Bio Green Med Solution (BGMS), the company finalized an Asset Purchase Agreement with Tethra Biosciences Inc. on October 6, 2025, selling certain assets including patent rights related to Plogosertib for $300,000, with a potential milestone payment of $170,000. This strategic move could significantly impact BGMS’s market positioning by transferring key intellectual property. Additionally, on October 7, 2025, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these updates, Spark, TipRanks’ AI Analyst, maintains an ‘Underperform’ rating for BGMS, citing financial strain, operational inefficiencies, and an unattractive valuation due to a negative P/E ratio and lack of dividend yield. The technical sentiment signal remains a ‘Strong Sell’, reflecting ongoing challenges for the company.

Spark’s Take on BGMS Stock

According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.

Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.

To see Spark’s full report on BGMS stock, click here.

More about Bio Green Med Solution

YTD Price Performance: -94.40%

Average Trading Volume: 812,176

Technical Sentiment Signal: Strong Sell

Current Market Cap: $11.31M